Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03134209 · ClinicalTrials.gov registry record · NA
A Study Investigating the Efficacy of Various Wound Closure Devices in Reducing Postoperative Wound Complications
A NA study of Joint Disease and Arthropathy, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT03134209 is a NA study of Joint Disease and Arthropathy that has completed, run by NYU Langone Health. The registered enrollment target is 160 participants, above the 132-participant average among 4 other Joint Disease trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03134209, a NA study of Joint Disease and Arthropathy, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
A single-center, phase IV, randomized, prospective study investigating the efficacy of various wound closure devices in reducing postoperative wound complications.
Conditions Studied
Interventions
- DEVICE Zipper surgical skin closure
- OTHER Monocryl + Dermabond
- OTHER Polyester mesh + Dermabond
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2017-04-26 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03134209
The ClinicalTrials.gov registry entry for NCT03134209 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 132-participant average among 4 other Joint Disease trials with a reported enrollment target (21% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Joint Disease appearing as the primary indexed condition, and to 3 interventions - of which Zipper surgical skin closure is the first listed.
NCT03134209 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03134209 about?
NCT03134209 is a clinical study titled "A Study Investigating the Efficacy of Various Wound Closure Devices in Reducing Postoperative Wound Complications". A single-center, phase IV, randomized, prospective study investigating the efficacy of various wound closure devices in reducing postoperative wound complications.
What is the current status of trial NCT03134209?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2017-04-26. Estimated completion is 2020-08-31.
What conditions does trial NCT03134209 study?
This clinical trial studies the following conditions: Joint Disease, Arthropathy.
What interventions are being tested in trial NCT03134209?
The interventions under investigation include: Zipper surgical skin closure (DEVICE), Monocryl + Dermabond (OTHER), Polyester mesh + Dermabond (OTHER).
Who is sponsoring clinical trial NCT03134209?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03134209 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Joint Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comprehensive Shoulder System Nano IDE
COMPLETED · NA
-
Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts
ACTIVE NOT RECRUITING
-
A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
COMPLETED · Phase 2
-
Quantitative Gait Analysis for Clinical Decision Making
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.